G1 Therapeutics Inc (GTHX)
4.53
-0.15
(-3.21%)
USD |
NASDAQ |
May 17, 16:00
4.53
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Cash and Short Term Investments (Quarterly): 65.19M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 65.19M |
December 31, 2023 | 82.16M |
September 30, 2023 | 94.35M |
June 30, 2023 | 104.23M |
March 31, 2023 | 116.32M |
December 31, 2022 | 145.07M |
September 30, 2022 | 122.98M |
June 30, 2022 | 143.96M |
March 31, 2022 | 183.02M |
December 31, 2021 | 221.19M |
September 30, 2021 | 212.09M |
June 30, 2021 | 244.02M |
March 31, 2021 | 278.97M |
December 31, 2020 | 207.31M |
September 30, 2020 | 238.34M |
Date | Value |
---|---|
June 30, 2020 | 234.27M |
March 31, 2020 | 242.40M |
December 31, 2019 | 269.21M |
September 30, 2019 | 299.93M |
June 30, 2019 | 324.91M |
March 31, 2019 | 347.80M |
December 31, 2018 | 369.29M |
September 30, 2018 | 390.52M |
June 30, 2018 | 188.23M |
March 31, 2018 | 194.39M |
December 31, 2017 | 103.81M |
September 30, 2017 | 118.38M |
June 30, 2017 | 132.68M |
March 31, 2017 | 37.73M |
December 31, 2016 | 47.30M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
65.19M
Minimum
Mar 2024
324.91M
Maximum
Jun 2019
191.50M
Average
209.70M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Amicus Therapeutics Inc | 239.60M |
Geron Corp | 443.05M |
Palatin Technologies Inc | 10.01M |
Oragenics Inc | 3.484M |
TG Therapeutics Inc | 209.78M |